SH2D4A and neoplasm: However, sensitivity of cells with SH2D4A deletion to FL3 treatment did not differ in cell viability assays and therefore, further mouse experiments are needed to evaluate FL3 treatment in regard to SH2D4A/chr8p deletion under physiological conditions in tumors with tumor microenvironment interaction in vivo.